Final Height in Children with Idiopathic Growth Hormone Deficiency Treated with Recombinant Human Growth Hormone: The Belgian Experience
peer reviewed ; BACKGROUND: The growth response to recombinant hGH (rhGH) treatment and final height of 61 Belgian children (32 boys) with idiopathic growth hormone deficiency (GHD) were studied. PATIENTS/METHODS: Two patient groups were compared: Group 1 with spontaneous puberty (n = 49), Group 2 with induced puberty (n = 12). The patients were treated with daily subcutaneous injections of rhGH in a dose of 0.5-0.7 IU/kg/week (0.17-0.23 mg/kg/week) from the mean +/- SD age of 11.9 +/- 3.1 years during 5.1 +/- 2.1 years. RESULTS: rhGH treatment induced a doubling of the height velocity during... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | journal article |
Erscheinungsdatum: | 2001 |
Verlag/Hrsg.: |
Karger
|
Schlagwörter: | Growth hormone deficiency / Growth hormone treatment / Final height / Idiopathic hypopituitarism / Puberty / Belgium / Human health sciences / Endocrinology / metabolism & nutrition / Sciences de la santé humaine / Endocrinologie / métabolisme & nutrition |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26504132 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://orbi.uliege.be/handle/2268/257205 |